Disease stratification in GCA and PMR: state of the art and future perspectives

A Tomelleri, KSM van der Geest, MA Khurshid… - Nature Reviews …, 2023 - nature.com
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related conditions
characterized by systemic inflammation, a predominant IL-6 signature, an excellent …

[HTML][HTML] Novel PET imaging of inflammatory targets and cells for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica

KSM van der Geest, M Sandovici, PH Nienhuis… - Frontiers in …, 2022 - frontiersin.org
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated
inflammatory diseases affecting patients above 50 years of age. Patients with GCA suffer …

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort

I Esen, S Arends, BD Nielsen, P Therkildsen… - RMD open, 2023 - rmdopen.bmj.com
Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are age-associated
inflammatory diseases that frequently overlap. Both diseases require long-term treatment …

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica

RD Reitsema, BC Hesselink, WH Abdulahad… - Frontiers in …, 2023 - frontiersin.org
Background Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) are overlapping
inflammatory diseases. Antigen-presenting cells (APCs), including monocytes and dendritic …

Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis

K Matsumoto, K Suzuki, H Yoshida, M Magi… - Arthritis research & …, 2023 - Springer
Background Giant cell arteritis (GCA) is a primary large-vessel vasculitis (LVV) of unknown
origin. Its management is a challenge due to the late onset of disease symptoms and …

[HTML][HTML] YKL-40 as a biomarker in various inflammatory diseases: A review

N Blazevic, D Rogic, S Pelajic, M Miler, G Glavcic… - Biochemia …, 2024 - hrcak.srce.hr
YKL-40 or Chitinase-3-Like Protein 1 (CHI3L1) is a highly conserved glycoprotein that binds
heparin and chitin in a non-enzymatic manner. It is a member of the chitinase protein family …

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

S Xu, WF Jiemy, AMH Boots, S Arends… - Arthritis Care & …, 2024 - Wiley Online Library
Objective Giant cell arteritis (GCA) is characterized by granulomatous inflammation of the
medium‐and large‐sized arteries accompanied by remodeling of the vessel wall. Fibroblast …

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

E Cantoni, I Merelli, D Stefanoni, A Tomelleri… - …, 2023 - academic.oup.com
Objective Trained immunity (TI) is a de facto memory program of innate immune cells,
characterized by immunometabolic and epigenetic changes sustaining enhanced …

[PDF][PDF] Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

F Buttgereit, A Palmowski, I Esen… - Arthritis and …, 2023 - research.rug.nl
Glucocorticoids have been the treatment mainstay for giant cell arteritis (GCA) for several
decades (1). Current guidelines recommend glucocorticoids as an induction therapy, and …

The role of PKM2 in diabetic microangiopathy

C Tu, L Wang, L Wei - … Syndrome and Obesity: Targets and Therapy, 2022 - Taylor & Francis
Diabetic microangiopathy is among the most common complications affecting patients with
diabetes, and includes both diabetic retinopathy (DR) and diabetic nephropathy (DKD) …